Zen OpinionZen has a leading edge product (s). I think we can all see the potential. While being positive on the long term the filings were not good. There are other issues switching from mining to biotech and this takes time. Where do they stand? What is the resource worth to a company that can source graphine elsewhere? Why keep the mine?
Zen may need to foucus on what are share valuations given potential to sell the mine vs no revenues and focus on expansion for production, source elsewhere. Just my take on it. We need to see revenue or focus on sales over the next 2-3 Q's. Sales in Ontario ? Perhaps new management that can move from mining to Bio products and testing?
Best regards
PS
Great Canadian Company when they get on track with production. Near term in transition.